Free Trial

Eliem Therapeutics (ELYM) Institutional Ownership

Eliem Therapeutics logo
$1.95 -0.06 (-2.99%)
As of 01/17/2025

Institutional Ownership Changes (13F Filings) for Eliem Therapeutics (NASDAQ:ELYM)

Current
Institutional Ownership
Percentage
69.76%
Number of
Institutional Buyers
(last 12 months)
25
Total
Institutional Inflows
(last 12 months)
$31.35M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$4.31M
Get ELYM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eliem Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELYM Institutional Buying and Selling by Quarter

Eliem Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/26/2024JPMorgan Chase & Co.12,776$65K0.0%+311.6%0.043%
11/19/2024Barclays PLC38,859$198K0.0%+1,428.1%0.131%
11/15/2024Barclays PLC38,859$198K0.0%+1,428.1%0.131%
11/15/2024Jane Street Group LLC10,907$56K0.0%N/A0.037%
11/15/2024Sphera Funds Management LTD.181,970$926K0.1%-15.4%0.612%
11/15/2024State Street Corp315,036$1.60M0.0%+433.9%1.059%
11/15/2024Samsara BioCapital LLC2,609,114$13.28M2.6%-20.0%8.770%
11/15/2024Point72 Asset Management L.P.590,946$3.01M0.0%N/A1.986%
11/15/2024Parkman Healthcare Partners LLC278,775$1.42M0.2%N/A0.937%
11/15/2024Ikarian Capital LLC175,100$891K0.1%+75.1%0.589%
11/15/2024Janus Henderson Group PLC3,606,495$18.30M0.0%+10.8%12.122%
11/14/2024Ally Bridge Group NY LLC1,229,292$6.26M3.3%+145.9%4.132%
11/14/2024MetLife Investment Management LLC17,769$90K0.0%N/A0.060%
11/13/2024Great Point Partners LLC248,168$1.26M0.4%N/A0.834%
11/13/2024Advantage Alpha Capital Partners LP48,169$245K0.1%N/A0.162%
11/13/2024The Manufacturers Life Insurance Company49,524$252K0.0%N/A0.166%
11/12/2024Valence8 US LP12,045$61K0.0%N/A0.040%
11/12/2024Charles Schwab Investment Management Inc.70,093$357K0.0%+309.2%0.236%
11/8/2024Segall Bryant & Hamill LLC58,411$297K0.0%N/A0.196%
10/29/2024Chicago Partners Investment Group LLC16,966$81K0.0%N/A0.057%
10/3/2024 SG Americas Securities LLC11,715$60K0.0%N/A0.039%
8/16/2024Driehaus Capital Management LLC696,057$4.95M0.0%-14.2%2.340%
8/15/2024Affinity Asset Advisors LLC1,670,661$11.88M1.4%N/A5.615%
8/14/2024Ally Bridge Group NY LLC500,000$3.56M2.1%N/A1.681%
8/9/2024Renaissance Technologies LLC37,000$263K0.0%+248.5%0.124%
8/9/2024Dimensional Fund Advisors LP12,560$89K0.0%N/A0.042%
8/1/2024Rhumbline Advisers8,233$59K0.0%N/A0.028%
7/26/2024Bank of New York Mellon Corp18,845$134K0.0%N/A0.063%
4/23/2024BML Capital Management LLC2,193,742$6.01M4.0%+0.6%7.914%
1/30/2024BML Capital Management LLC2,180,000$5.89M4.4%+12.5%7.907%
1/26/2024Cerity Partners LLC13,821$37K0.0%N/A0.050%
11/13/2023Silverarc Capital Management LLC121,110$319K0.1%-75.5%0.447%
10/23/2023BML Capital Management LLC1,938,263$5.10M4.7%+22.4%7.155%
8/15/2023Silverarc Capital Management LLC494,089$1.38M0.4%+1.7%1.830%
8/14/2023Driehaus Capital Management LLC810,593$2.27M0.0%+20.3%3.003%
7/24/2023BML Capital Management LLC1,583,170$4.43M4.0%-4.5%5.866%
4/14/2023BML Capital Management LLC1,658,170$4.81M4.2%-9.1%6.148%
2/14/2023Driehaus Capital Management LLC551,942$2.03M0.0%+58.3%2.077%
2/13/2023BML Capital Management LLC1,825,134$6.70M6.4%N/A6.869%
2/1/2023Bank of Montreal Can25,244$93K0.0%N/A0.095%
Is Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.
11/8/2022Atom Investors LP67,074$217K0.1%+154.9%0.252%
10/28/2022Silverarc Capital Management LLC402,088$1.30M0.4%-43.6%1.513%
8/16/2022Parkwood LLC67,202$67K0.2%+63.4%0.253%
7/25/2022Silverarc Capital Management LLC713,009$2.15M0.7%+707.7%2.684%
5/12/2022Monashee Investment Management LLC227,201$1.91M0.6%-24.3%0.855%
5/9/2022Qube Research & Technologies Ltd15,874$133K0.0%N/A0.060%
2/19/2022Woodline Partners LP373,368$3.91M0.1%-3.6%1.406%
2/15/2022Samlyn Capital LLC1,703,546$17.82M0.2%+1.3%6.417%
2/11/2022Parkwood LLC30,609$320K0.1%N/A0.115%
2/7/2022Monashee Investment Management LLC300,000$3.14M0.8%-1.7%1.130%
2/2/2022New York State Common Retirement Fund3,359$35K0.0%N/A0.013%
1/28/2022Allspring Global Investments Holdings LLC2,880$30K0.0%N/A0.011%
12/29/2021Hudson Bay Capital Management LP100,000$1.80M0.0%N/A0.377%
11/15/2021Tudor Investment Corp Et Al287,294$5.17M0.0%N/A1.082%
11/15/2021RA Capital Management L.P.13,150,849$236.45M3.3%N/A49.536%
11/15/2021Caas Capital Management LP75,000$1.35M0.0%N/A0.283%
11/12/2021Geode Capital Management LLC76,904$1.38M0.0%N/A0.290%
11/10/2021Goldman Sachs Group Inc.165,952$2.98M0.0%N/A0.625%
11/9/2021BlackRock Inc.332,126$5.97M0.0%N/A1.251%
11/9/2021Monashee Investment Management LLC305,233$5.49M1.0%N/A1.150%
11/4/2021Deutsche Bank AG4,063$73K0.0%N/A0.015%
(Data available from 1/1/2016 forward)

ELYM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELYM shares?

During the previous two years, 30 institutional investors and hedge funds held shares of Eliem Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($18.30M), Samsara BioCapital LLC ($13.28M), Affinity Asset Advisors LLC ($11.88M), Ally Bridge Group NY LLC ($6.26M), BML Capital Management LLC ($6.01M), Driehaus Capital Management LLC ($4.95M), and Point72 Asset Management L.P. ($3.01M).Learn more on ELYM's institutional investors.

What percentage of Eliem Therapeutics stock is owned by institutional investors?

69.76% of Eliem Therapeutics stock is owned by institutional investors. Learn more on ELYM's institutional investor holdings.

Which institutional investors have been buying Eliem Therapeutics stock?

Of the 28 institutional investors that purchased Eliem Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($2.44M), Affinity Asset Advisors LLC ($1.67M), Ally Bridge Group NY LLC ($1.23M), Point72 Asset Management L.P. ($590.95K), Janus Henderson Group PLC ($352.51K), Driehaus Capital Management LLC ($340.28K), and Parkman Healthcare Partners LLC ($278.78K).

How much institutional buying is happening at Eliem Therapeutics?

Institutional investors have bought a total of 7,951,459 shares in the last 24 months. This purchase volume represents approximately $40.23M in transactions.

Which Eliem Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Eliem Therapeutics stock in the last 24 months: Samsara BioCapital LLC ($652.28K), Silverarc Capital Management LLC ($372.98K), BML Capital Management LLC ($241.96K), Driehaus Capital Management LLC ($115.62K), and Sphera Funds Management LTD. ($33.21K).

How much institutional selling is happening at Eliem Therapeutics?

Institutional investors have sold a total of 1,416,054 shares in the last 24 months. This volume of shares sold represents approximately $5.99M in transactions.



This page (NASDAQ:ELYM) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners